Ticker Details
Savara Inc. Savara Inc is a pharmaceutical company. The company develops novel therapies for the treatment of serious or life-threatening rare respiratory diseases.
IPO Date:	March 11, 2013
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$1.15B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.14 | 3.66%
Avg Daily Range (30 D):	$0.18 | 3.23%
Avg Daily Range (90 D):	$0.16 | 2.84%

Institutional Daily Volume
Avg Daily Volume:	.71M
Avg Daily Volume (30 D):	1.37M
Avg Daily Volume (90 D):	1.27M

Trade Size
Avg Trade Size (Sh.):	161
Avg Trade Size (Sh.) (30 D):	97
Avg Trade Size (Sh.) (90 D):	93

Institutional Trades
Total Institutional Trades:	698
Avg Institutional Trade:	$1.6M
Avg Institutional Trade (30 D):	$1.35M
Avg Institutional Trade (90 D):	$1.57M
Avg Institutional Trade Volume:	.35M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$1.77M
Avg Closing Trade (30 D):	$1.25M
Avg Closing Trade (90 D):	$1.63M
Avg Closing Volume:	368.86K

News

Jun 8, 2026 @ 8:05 PM Savara Announces Chief Financial and Administrativ... Source: Business Wire

May 27, 2026 @ 8:05 PM Savara Announces Participation in the 2026 Jefferi... Source: Business Wire

May 11, 2026 @ 8:05 PM Savara Announces Participation in the H.C. Wainwri... Source: Business Wire

Mar 6, 2026 @ 9:05 PM Savara Provides Regulatory Update on the MOLBREEVI... Source: Business Wire

Mar 4, 2026 @ 9:05 PM Savara Announces Participation in 2026 Citizens Li... Source: Business Wire

Financials
	TTM	Q1 2026	Q4 2025
Basic EPS	$-.16	$-.15	$-.13
Diluted EPS	$-.16	$-.15	$-.13
Revenue	$M	$M	$M
Gross Profit
Net Income / Loss	$-40.23M	$-37.28M	$-32.24M
Operating Income / Loss	$-40.97M	$-38.99M	$-33.42M
Cost of Revenue
Net Cash Flow	$3.04M	$5.54M	$16.94M
PE Ratio

Splits
Apr 28, 2017	1:70
Apr 26, 2010	1:25
Jul 26, 2000	1:2